Mercedes
Salgado Fernández
Hospital Ramón y Cajal
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Ramón y Cajal (8)
2023
-
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2911-2925
2022
2018
-
From first line to sequential treatment in the management of metastatic pancreatic cancer
Journal of Cancer, Vol. 9, Núm. 11, pp. 1978-1988
-
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer
British Journal of Cancer
-
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: The ANICE-PaC study
BMC Cancer, Vol. 18, Núm. 1
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
-
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
European Journal of Cancer, Vol. 82, pp. 16-24
2014
-
A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
Cancer Letters, Vol. 351, Núm. 1, pp. 30-40